Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81

Detalles Bibliográficos
Autores principales: Mishra, Ankit, Mandal, Swarnendu, Das, Manoj K., Nayak, Prasant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Letters to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033241/
https://www.ncbi.nlm.nih.gov/pubmed/33850371
http://dx.doi.org/10.4103/iju.IJU_538_20
_version_ 1783676373488893952
author Mishra, Ankit
Mandal, Swarnendu
Das, Manoj K.
Nayak, Prasant
author_facet Mishra, Ankit
Mandal, Swarnendu
Das, Manoj K.
Nayak, Prasant
author_sort Mishra, Ankit
collection PubMed
description
format Online
Article
Text
id pubmed-8033241
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80332412021-04-12 Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81 Mishra, Ankit Mandal, Swarnendu Das, Manoj K. Nayak, Prasant Indian J Urol Letters to Editor Wolters Kluwer - Medknow 2021 2021-01-01 /pmc/articles/PMC8033241/ /pubmed/33850371 http://dx.doi.org/10.4103/iju.IJU_538_20 Text en Copyright: © 2021 Indian Journal of Urology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Letters to Editor
Mishra, Ankit
Mandal, Swarnendu
Das, Manoj K.
Nayak, Prasant
Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81
title Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81
title_full Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81
title_fullStr Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81
title_full_unstemmed Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81
title_short Re; Sarmah PB, Ehsanullah SA, Sarmah BD. Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian J Urol 2020;36:276-81
title_sort re; sarmah pb, ehsanullah sa, sarmah bd. long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. indian j urol 2020;36:276-81
topic Letters to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033241/
https://www.ncbi.nlm.nih.gov/pubmed/33850371
http://dx.doi.org/10.4103/iju.IJU_538_20
work_keys_str_mv AT mishraankit resarmahpbehsanullahsasarmahbdlongtermfollowupandoutcomesofpercutaneousnephronsparingsurgeryforuppertracturothelialcarcinomaindianjurol20203627681
AT mandalswarnendu resarmahpbehsanullahsasarmahbdlongtermfollowupandoutcomesofpercutaneousnephronsparingsurgeryforuppertracturothelialcarcinomaindianjurol20203627681
AT dasmanojk resarmahpbehsanullahsasarmahbdlongtermfollowupandoutcomesofpercutaneousnephronsparingsurgeryforuppertracturothelialcarcinomaindianjurol20203627681
AT nayakprasant resarmahpbehsanullahsasarmahbdlongtermfollowupandoutcomesofpercutaneousnephronsparingsurgeryforuppertracturothelialcarcinomaindianjurol20203627681

Ejemplares similares